, /PRNewswire/ -- Manifold, an AI-powered clinical data platform streamlining manual workflows in cancer research, today announced that the American Cancer Society (ACS) will leverage their platform to modernize its study management and support the organization's groundbreaking study. With Manifold, the American Cancer Society is streamlining all aspects of population research, including simplifying the participant experience for surveys and collection, and enhancing how study managers design dynamic surveys, engage with participants through personalized email and SMS outreach, and monitor participant data over many years. Many organizations rely on legacy systems and spreadsheets to track participant data and manage a study.
These manual workflows require countless hours of administrative time from teams that are often under-resourced. Working with ACS to understand the challenges that cancer researchers face, Manifold saw an opportunity to streamline study operations, create an engaging, consumer-friendly UI, leverage the modern data technology stack, and, ultimately, retire legacy systems. "At Manifold, we believe that the unsung heroes of cancer population science – the participants and study managers – deserve the kind of delightful app experience they have in their daily lives," said , Manifold's CEO.
"The Manifold Observational Study automates manual steps wherever possible, resulting in more engaged participants and empowered study managers. We're honored to suppo.
